Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
222 people get Q articles and Market Currents by email alert.
Get email alerts on Q »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
There are no Transcripts on Q.
-
at CNBC.com (May 9, 2013)
-
at CNBC.com (May 9, 2013)
Q vs. ETF Alternatives
Company Description
Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 9, 7:39 PM Quintiles (Q) finshed its IPO debut today in the green, with the company’s shares ending the day at $42.11, up more than 5% from their initial offering price of $40. The company provides testing and diagnostic services to biopharmaceutical companies, and could see a boon to business with the implementation of President Obama’s health-care overhaul. Comment! [Healthcare, On the Move]
We currently have no instablog posts on this stock.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.